159 related articles for article (PubMed ID: 36014430)
1. 2-Arachidonoylglycerol Synthesis: Facile and Handy Enzymatic Method That Allows to Avoid Isomerization.
Ottria R; Casati S; Rota P; Ciuffreda P
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014430
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.
Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ
Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019
[TBL] [Abstract][Full Text] [Related]
3. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids and diacylglycerol kinase activity.
Gantayet A; Jegatheswaran J; Jayakumaran G; Topham MK; Epand RM
Biochim Biophys Acta; 2011 Apr; 1808(4):1050-3. PubMed ID: 21194521
[TBL] [Abstract][Full Text] [Related]
5. 1-, 2- and 3-AG as substrates of the endocannabinoid enzymes and endogenous ligands of the cannabinoid receptor 1.
Farah SI; Hilston S; Tran N; Zvonok N; Makriyannis A
Biochem Biophys Res Commun; 2022 Feb; 591():31-36. PubMed ID: 34995983
[TBL] [Abstract][Full Text] [Related]
6. Brain regional cannabinoid CB(1) receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice.
Aaltonen N; Riera Ribas C; Lehtonen M; Savinainen JR; Laitinen JT
Eur J Pharm Sci; 2014 Jan; 51():87-95. PubMed ID: 24012970
[TBL] [Abstract][Full Text] [Related]
7. Radiometric Assay of ABHD2 Activity.
Fazio D; Criscuolo E; Maccarrone M
Methods Mol Biol; 2023; 2576():299-305. PubMed ID: 36152197
[TBL] [Abstract][Full Text] [Related]
8. Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.
Ueda N; Tsuboi K; Uyama T; Ohnishi T
Biofactors; 2011; 37(1):1-7. PubMed ID: 21328621
[TBL] [Abstract][Full Text] [Related]
9. Bidirectional roles of the brain 2-arachidonoyl-sn-glycerol in the centrally administered vasopressin-induced adrenomedullary outflow in rats.
Shimizu T; Yokotani K
Eur J Pharmacol; 2008 Mar; 582(1-3):62-9. PubMed ID: 18234185
[TBL] [Abstract][Full Text] [Related]
10. P2X7 receptors control 2-arachidonoylglycerol production by microglial cells.
Witting A; Walter L; Wacker J; Möller T; Stella N
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3214-9. PubMed ID: 14976257
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations.
Siegmund SV; Wojtalla A; Schlosser M; Zimmer A; Singer MV
Biochem Biophys Res Commun; 2013 Jul; 437(1):48-54. PubMed ID: 23806692
[TBL] [Abstract][Full Text] [Related]
12. Molecular reorganization of endocannabinoid signalling in Alzheimer's disease.
Mulder J; Zilberter M; Pasquaré SJ; Alpár A; Schulte G; Ferreira SG; Köfalvi A; Martín-Moreno AM; Keimpema E; Tanila H; Watanabe M; Mackie K; Hortobágyi T; de Ceballos ML; Harkany T
Brain; 2011 Apr; 134(Pt 4):1041-60. PubMed ID: 21459826
[TBL] [Abstract][Full Text] [Related]
13. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes.
Saario SM; Savinainen JR; Laitinen JT; Järvinen T; Niemi R
Biochem Pharmacol; 2004 Apr; 67(7):1381-7. PubMed ID: 15013854
[TBL] [Abstract][Full Text] [Related]
14. A methodology for radiolabeling of the endocannabinoid 2-arachidonoylglycerol (2-AG).
Duclos RI; Johnston M; Vadivel SK; Makriyannis A; Glaser ST; Gatley SJ
J Org Chem; 2011 Apr; 76(7):2049-55. PubMed ID: 21370840
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
[TBL] [Abstract][Full Text] [Related]
17. Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy.
Alhouayek M; Masquelier J; Muccioli GG
Drug Discov Today; 2014 Mar; 19(3):295-304. PubMed ID: 23891880
[TBL] [Abstract][Full Text] [Related]
18. Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS.
Murataeva N; Straiker A; Mackie K
Br J Pharmacol; 2014 Mar; 171(6):1379-91. PubMed ID: 24102242
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.
Sugiura T; Kobayashi Y; Oka S; Waku K
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):173-92. PubMed ID: 12052034
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous UPLC-MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction.
Zoerner AA; Batkai S; Suchy MT; Gutzki FM; Engeli S; Jordan J; Tsikas D
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():161-71. PubMed ID: 21752730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
